SCHEMBL4904701

SCHEMBL4904701

CCN(Sc1ccc(Oc2ccc(OC(C)C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
MCL1 Q07820 8/20 0.39
BCL2L1 Q07817 4/20 0.39
ALDH1A1 P00352 1/20 0.38
NR1H4 Q96RI1 1/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CNR2 P34972 2/20 0.36
MMP3 P08254 2/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP14 P50281 1/20 0.36
LMNA P02545 3/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905869 0.91 ALDH1A1 (0.42) POLBALDH1A1MMP3MMP2MMP9
SCHEMBL4903896 0.90 LMNA (0.46) POLBMCL1BCL2L1ALDH1A1NR1H4
SCHEMBL4898271 0.90 POLB (0.44) POLBMCL1BCL2L1ALDH1A1NR1H4
SCHEMBL4894435 0.90 POLB (0.52) POLBMCL1BCL2L1ALDH1A1L3MBTL1
SCHEMBL4905724 0.89 POLB (0.43) POLBMCL1BCL2L1ALDH1A1NR1H4
SCHEMBL4905300 0.88 POLB (0.43) POLBMCL1BCL2L1ALDH1A1NR1H4
SCHEMBL4906518 0.88 POLB (0.43) POLBMCL1BCL2L1ALDH1A1MMP2
SCHEMBL4905969 0.88 POLB (0.43) POLBMCL1BCL2L1ALDH1A1NR1H4
SCHEMBL4899894 0.85 LMNA (0.43) POLBMCL1BCL2L1ALDH1A1L3MBTL1
SCHEMBL4905243 0.85 KDM4E (0.42) POLBALDH1A1KDM4ECNR2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD POLB 1488/4885MCL1 4160/4885BCL2L1 2170/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885MCL1 4319/4885BCL2L1 2219/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD POLB 1807/4885MCL1 4319/4885BCL2L1 2219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.